We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Price loading...
Springer Updates on Clostridium difficile in Europe: Advances in Microbiology, Infectious Diseases and Public Health Volume 8: 1050
Price data last checked 103 day(s) ago - refreshing...
Price History & Forecast
No Price Data Available
Price history will appear here once data is collected from Amazon.
Price Distribution
No price data available for histogram
Description
Product Description Foreword (P. Mastrantonio and M. Rupnik).- Economic burden of CDI in European countries (E. Reigadas and E. Bouza).- The need for European surveillance of CDI(C. Wiuff, A.Lan Banks, F. Fitzpatrick, L. Cottom).- Diagnostic guidance for C. difficile infections (M.J.T. Crobach,A.Baktash, N. Duszenko, E.J. Kuijper).- Ribotypes and new virulent strains across Europe (J. Couturier, K. Davies, C. Gateau, F. Barbut).- Comparative genomics of C. difficile strains (S. Janezic, J.R.Garneau, M. Monot).- Cellular uptake and mode-of-action of Clostridium difficile toxins (P.Papatheodorou, H. Barth, N. Minton, K. Aktories).- Clostridium difficile biofilm (C. Vuotto, G. Donelli, A. Buckley, C. Chilton).- European practice for CDI treatment (F. Fitzpatrick, M. Skally, M. Brady, K. Burns, C. Rooney, M.H. Wilcox).- Antibiotic resistances of Clostridium difficile (P. Spigaglia, P. Mastrantonio, F. Barbanti).- Probiotics for prevention and treatment of Clostridium difficile infection (L. Valdés-Varela, M. Gueimonde, P. Ruas-Madiedo).- Faecal microbiota transplantation as emerging treatment in European countries (M. Maida, J. McIlroy, G. Ianiro, G. Cammarota).- Immunization strategies against Clostridium difficile (J.F. Bruxelle, S. Péchiné, A. Collignon).- Non-human C. difficile reservoirs and sources: animals, food, environment (C. Rodriguez Diaz, C. Seyboldt , M. Rupnik).- The ESCMIDStudy Group for Clostridium difficile: history, role and perspectives (J.E. Coia and E.J. Kuijper). From the Back Cover This book outlines the currently available clinical, epidemiological and experimental data on Clostridium difficile infection (CDI) with special emphasis on studies and results achieved in Europe. The incidence and severity of CDI has increased significantly over the last decade, and the book explains why C. difficile, recently reclassified as Clostridioides difficile, remains a significant challenge, also from economic perspective, to health care systems all over the world. The different reservoirs of this ubiquitous microorganism are reviewed as well as the different factors contributing to its virulence, such as toxins and biofilm formation. The rapid evolution of antibiotic resistance is clearly a concern and in a specific way can influence the CDI epidemiology. Additionally, new emerging strains and comparative genomics studies are discussed for their relevance from epidemiological and evolutionary point of view. The book also gives an overview on diagnostics, therapy and surveillance, all of which are still challenging. Therefore, a closer look is taken on the effect of probiotics as an alternative to antibiotics, for prevention and treatment of CDI. Fecal transplantation from healthy donors, passive immunotherapies and vaccines for patients with recurrences are also discussed in dedicated chapters. The book closes with a summary of the history and the achievements of the European Society of Clinical Microbiology and Infectious Diseases Study Group for Clostridium difficile (ESGCD) written by the current and past presidents of the Society. It is the aim of this book to raise awareness on CDI and to disseminate updated information on its prevention, diagnosis and treatment. About the Author Dr.P.Mastrantonio has served till 2015 as research director in the Department of Infectious, Parasitic and Immune-mediated Diseases of the Italian National Institute of Health (ISS). She completed her studies in Biological Sciences at the University of Rome “La Sapienza”, Italy. She has been worked in the field of clinical bacteriology at ISS where she was appointed Director of the Laboratory of Gastroenteric and Neurologic Bacterial Diseases. In particular, she has been involved in international study groups on Clostridium difficile contributing to European surveillance studies to monitor the epidemiology of C.difficile infection. She was Executive Committee member of the ESCMID Study Group on C. diffici
Product Specifications
- Brand
- Springer
- Format
- paperback
- ASIN
- 331989210X
- Domain
- Amazon UK
- Release Date
- 04 June 2019
- Listed Since
- 14 January 2019
Barcode
No barcode data available
Similar Products You Might Like
94% match
Advances in Microbiology, Infectious Diseases and Public Health 2
Springer
£119.91
18 Apr 2026
94% match
Advances in Microbiology, Infectious Diseases and Public Health: Volume 14: 1282 (Advances in Experimental Medicine and Biology, 1282)
Springer
£107.33
09 Mar 2026
94% match
Advances in Microbiology, Infectious Diseases and Public Health: Volume 14: 1282 (Advances in Experimental Medicine and Biology, 1282)
Springer
£75.05
07 Mar 2026
94% match
Advances in Microbiology, Infectious Diseases and Public Health: Volume 1: 897 (Advances in Experimental Medicine and Biology, 897)
Springer
£73.91
20 Feb 2026
94% match
Antibiotic Associated Diarrhoea and Colitis: The role of Clostridium difficile in gastrointestinal disorders: 5 (Developments in Gastroenterology, 5)
Springer
£103.61
21 Feb 2026
94% match
Advances in Microbiology, Infectious Diseases and Public Health: Volume 15: 1323 (Advances in Experimental Medicine and Biology, 1323)
Springer
£91.63
09 Mar 2026
94% match
Gastroenterologische Infektiologie
De Gruyter
£73.99
21 Feb 2026
94% match
Superbugs -- Clostridium difficile & Klebsiella pneumoniae: Recognition, Prevention & Treatment (Allergies and Infectious Diseases)
£104.99
07 Jan 2026
93% match
How to Overcome the Antibiotic Crisis: Facts, Challenges, Technologies and Future Perspectives: 398 (Current Topics in Microbiology and Immunology, 398)
Springer
£119.08
18 Apr 2026
93% match
How to Overcome the Antibiotic Crisis: Facts, Challenges, Technologies and Future Perspectives: 398 (Current Topics in Microbiology and Immunology, 398)
Springer
£126.23
08 Feb 2026
93% match
Efflux-Mediated Antimicrobial Resistance in Bacteria: Mechanisms, Regulation and Clinical Implications
Adis
£140.72
10 Mar 2026
93% match
Chronisch entzündliche Darmerkrankungen: Ätiopathogenetische und differentialdiagnostische Aspekte intestinaler Infektionskrankheiten: 2001 (Gastroenterologie Update, 2001)
Springer
£46.99
07 Mar 2026
93% match
Antimicrobial Drug Resistance: Mechanisms of Drug Resistance, Volume 1 (Infectious Disease)
Humana
£193.64
13 Dec 2025
93% match
Springer - Recent Advances in Applied Microbiology Book
Springer
£113.03
18 Apr 2026
93% match
Immunomodulators and Combinatorial Approaches to Tackle Klebsiella
£66.72
05 Mar 2026
93% match
E Coli O157
£95.50
26 Feb 2026
93% match
Infectious Diseases and Your Health
Springer
£103.81
09 Mar 2026
93% match
Enteric Infections and Immunity (Infectious Agents and Pathogenesis)
Springer
£105.11
04 Mar 2026
93% match
Nano-Antimicrobials: Progress and Prospects
Springer
£147.75
31 Jan 2026
93% match
Probiotic Bacteria and Postbiotic Metabolites: Role in Animal and Human Health: 2 (Microorganisms for Sustainability, 2)
£109.51
25 Jan 2026
93% match
Advances in Microbiology, Infectious Diseases and Public Health: Volume 1: 897 (Advances in Experimental Medicine and Biology, 897)
Springer
£78.84
07 Mar 2026
93% match
Antimicrobial Resistance in the 21st Century (Emerging Infectious Diseases of the 21st Century)
Springer
£124.31
09 Mar 2026
93% match
Antibiotic Resistance in the Environment: A Worldwide Overview: 91 (The Handbook of Environmental Chemistry, 91)
Springer
£221.76
11 Feb 2026
93% match
Antibacterial Drug Discovery to Combat MDR: Natural Compounds, Nanotechnology and Novel Synthetic Sources
Springer
£137.41
25 Jan 2026